Literature DB >> 16282478

Molecular characterization of adeno-associated viruses infecting children.

Chun-Liang Chen1, Ryan L Jensen, Bruce C Schnepp, Mary J Connell, Richard Shell, Thomas J Sferra, Jeffrey S Bartlett, K Reed Clark, Philip R Johnson.   

Abstract

Although adeno-associated virus (AAV) infection is common in humans, the biology of natural infection is poorly understood. Since it is likely that many primary AAV infections occur during childhood, we set out to characterize the frequency and complexity of circulating AAV isolates in fresh and archived frozen human pediatric tissues. Total cellular DNA was isolated from 175 tissue samples including freshly collected tonsils (n = 101) and archived frozen samples representing spleen (n = 21), lung (n = 16), muscle (n = 15), liver (n = 19), and heart (n = 3). Samples were screened for the presence of AAV and adenovirus sequences by PCR using degenerate primers. AAV DNA was detected in 7 of 101 (7%) tonsil samples and two of 74 other tissues (one spleen and one lung). Adenovirus sequences were identified in 19 of 101 tonsils (19%), but not in any other tissues. Complete capsid gene sequences were recovered from all nine AAV-positive tissues. Sequence analyses showed that eight of the capsid sequences were AAV2-like (approximately 98% amino acid identity), while the single spleen isolate was intermediate between serotypes 2 and 3. Comparison to the available AAV2 crystal structure revealed that the majority of the amino acid substitutions mapped to surface-exposed hypervariable domains. To further characterize the AAV capsid structure in these samples, we used a novel linear rolling-circle amplification method to amplify episomal AAV DNA and isolate infectious molecular clones from several human tissues. Serotype 2-like viruses were generated from these DNA clones and interestingly, failed to bind to a heparin sulfate column. Inspection of the capsid sequence from these two clones (and the other six AAV2-like isolates) revealed that they lacked arginine residues at positions 585 and 588 of the capsid protein, which are thought to be essential for interaction with the heparin sulfate proteoglycan coreceptor. These data provide a framework with which to explore wild-type AAV persistence in vivo and provide additional tools to further define the biodistribution and form of AAV in human tissues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282478      PMCID: PMC1287571          DOI: 10.1128/JVI.79.23.14781-14792.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Insertional mutagenesis of AAV2 capsid and the production of recombinant virus.

Authors:  J E Rabinowitz; W Xiao; R J Samulski
Journal:  Virology       Date:  1999-12-20       Impact factor: 3.616

2.  MEGA2: molecular evolutionary genetics analysis software.

Authors:  S Kumar; K Tamura; I B Jakobsen; M Nei
Journal:  Bioinformatics       Date:  2001-12       Impact factor: 6.937

3.  Adeno-associated viruses undergo substantial evolution in primates during natural infections.

Authors:  Guangping Gao; Mauricio R Alvira; Suryanarayan Somanathan; You Lu; Luk H Vandenberghe; John J Rux; Roberto Calcedo; Julio Sanmiguel; Zahra Abbas; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

4.  The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

Authors:  Qing Xie; Weishu Bu; Smita Bhatia; Joan Hare; Thayumanasamy Somasundaram; Arezki Azzi; Michael S Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

5.  Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).

Authors:  K Erles; P Sebökovà; J R Schlehofer
Journal:  J Med Virol       Date:  1999-11       Impact factor: 2.327

6.  Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses.

Authors:  V V Lukashov; J Goudsmit
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.

Authors:  P Wu; W Xiao; T Conlon; J Hughes; M Agbandje-McKenna; T Ferkol; T Flotte; N Muzyczka
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.

Authors:  W Shi; G S Arnold; J S Bartlett
Journal:  Hum Gene Ther       Date:  2001-09-20       Impact factor: 5.695

9.  Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.

Authors:  Guang-Ping Gao; Mauricio R Alvira; Lili Wang; Roberto Calcedo; Julie Johnston; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

10.  Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer.

Authors:  M Hildinger; A Auricchio; G Gao; L Wang; N Chirmule; J M Wilson
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

View more
  35 in total

1.  Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness.

Authors:  Defne Amado; Federico Mingozzi; Daniel Hui; Jeannette L Bennicelli; Zhangyong Wei; Yifeng Chen; Erin Bote; Rebecca L Grant; Jeffrey A Golden; Kristina Narfstrom; Nasreen A Syed; Stephen E Orlin; Katherine A High; Albert M Maguire; Jean Bennett
Journal:  Sci Transl Med       Date:  2010-03-03       Impact factor: 17.956

2.  The perils of pathogen discovery: origin of a novel parvovirus-like hybrid genome traced to nucleic acid extraction spin columns.

Authors:  Samia N Naccache; Alexander L Greninger; Deanna Lee; Lark L Coffey; Tung Phan; Annie Rein-Weston; Andrew Aronsohn; John Hackett; Eric L Delwart; Charles Y Chiu
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D.

Authors:  Jerry R Mendell; Louise R Rodino-Klapac; Xiomara Q Rosales; Brian D Coley; Gloria Galloway; Sarah Lewis; Vinod Malik; Chris Shilling; Barry J Byrne; Thomas Conlon; Katherine J Campbell; William G Bremer; Laura E Taylor; Kevin M Flanigan; Julie M Gastier-Foster; Caroline Astbury; Janaiah Kota; Zarife Sahenk; Christopher M Walker; K Reed Clark
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

4.  Proteolytic mapping of the adeno-associated virus capsid.

Authors:  Kim Van Vliet; Veronique Blouin; Mavis Agbandje-McKenna; Richard O Snyder
Journal:  Mol Ther       Date:  2006-09-27       Impact factor: 11.454

5.  Structure of adeno-associated virus serotype 8, a gene therapy vector.

Authors:  Hyun-Joo Nam; Michael Douglas Lane; Eric Padron; Brittney Gurda; Robert McKenna; Erik Kohlbrenner; George Aslanidi; Barry Byrne; Nicholas Muzyczka; Sergei Zolotukhin; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

Review 6.  AAV: An Overview of Unanswered Questions.

Authors:  Kenneth I Berns; Nicholas Muzyczka
Journal:  Hum Gene Ther       Date:  2017-04       Impact factor: 5.695

7.  Host cell DNA repair pathways in adeno-associated viral genome processing.

Authors:  Vivian W Choi; Douglas M McCarty; R Jude Samulski
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

8.  Characterization of adeno-associated virus genomes isolated from human tissues.

Authors:  Bruce C Schnepp; Ryan L Jensen; Chun-Liang Chen; Philip R Johnson; K Reed Clark
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

9.  Prevalence of human bocavirus in human tonsils and adenoids.

Authors:  Nathalie Clément; Gino Battaglioli; Ryan L Jensen; Bruce C Schnepp; Philip R Johnson; Kirsten St George; R Michael Linden
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

10.  Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints.

Authors:  L H Vandenberghe; E Breous; H-J Nam; G Gao; R Xiao; A Sandhu; J Johnston; Z Debyser; M Agbandje-McKenna; J M Wilson
Journal:  Gene Ther       Date:  2009-12       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.